CVApr 10

UniSemAlign: Text-Prototype Alignment with a Foundation Encoder for Semi-Supervised Histopathology Segmentation

arXiv:2604.0916931.9h-index: 3Has Code
AI Analysis

This work addresses the problem of scarce annotations in histopathology segmentation for medical imaging researchers, presenting an incremental improvement over existing methods.

The paper tackles the challenge of semi-supervised semantic segmentation in computational pathology by proposing UniSemAlign, a framework that aligns visual features with text and prototypes to improve segmentation accuracy, achieving Dice improvements of up to 2.6% on GlaS and 8.6% on CRAG with only 10% labeled data.

Semi-supervised semantic segmentation in computational pathology remains challenging due to scarce pixel-level annotations and unreliable pseudo-label supervision. We propose UniSemAlign, a dual-modal semantic alignment framework that enhances visual segmentation by injecting explicit class-level structure into pixel-wise learning. Built upon a pathology-pretrained Transformer encoder, UniSemAlign introduces complementary prototype-level and text-level alignment branches in a shared embedding space, providing structured guidance that reduces class ambiguity and stabilizes pseudo-label refinement. The aligned representations are fused with visual predictions to generate more reliable supervision for unlabeled histopathology images. The framework is trained end-to-end with supervised segmentation, cross-view consistency, and cross-modal alignment objectives. Extensive experiments on the GlaS and CRAG datasets demonstrate that UniSemAlign substantially outperforms recent semi-supervised baselines under limited supervision, achieving Dice improvements of up to 2.6% on GlaS and 8.6% on CRAG with only 10% labeled data, and strong improvements at 20% supervision. Code is available at: https://github.com/thailevann/UniSemAlign

Foundations

The foundational work for this paper's niche, ranked by how specifically the neighbourhood builds on it — not by global fame.

Your Notes